Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Sanofi Opens $77 Million Clinical Big Data R&D Facility in Chengdu

publication date: Jul 2, 2018

Sanofi launched a $77 million Global R&D Operations Hub in Chengdu, which will focus on digitalization and big data analysis for clinical trials. The China R&D center will be the third pillar of Sanofi Global Clinical Sciences and Operations, joining facilities in France and the United States. The Hub will support clinical R&D of Sanofi's innovative drugs, managing global multi-center clinical trials data and files. In 2014, Sanofi announced an Asia-Pacific drug development R&D Center in Shanghai. More details....

Stock Symbol: (NYSE: SNY)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.